A detailed history of Meridian Management CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Meridian Management CO holds 1,328 shares of ABBV stock, worth $219,106. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,328
Previous 1,254 5.9%
Holding current value
$219,106
Previous $215,000 21.86%
% of portfolio
0.07%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$163.84 - $199.33 $12,124 - $14,750
74 Added 5.9%
1,328 $262,000
Q2 2024

Aug 08, 2024

BUY
$154.79 - $180.76 $154 - $180
1 Added 0.08%
1,254 $215,000
Q1 2024

May 02, 2024

BUY
$159.82 - $182.1 $958 - $1,092
6 Added 0.48%
1,253 $228,000
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $171,587 - $193,247
1,247 New
1,247 $193,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $292B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Meridian Management CO Portfolio

Follow Meridian Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meridian Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Meridian Management CO with notifications on news.